Wed.Aug 17, 2022

article thumbnail

The Most Most-Overlooked High-Value Medical Sales Skill

Medical Sales Guru

Medical sales requires many skills, such as relationship skills, selling skills, and product knowledge. But there is one essential skill set that gets little attention. Competency in this area is often assumed. Big mistake! Learn what it is, why it’s necessary, and some ways for you to start gaining and using it now. Medical sales requires many skills, such as relationship skills, selling skills, and product knowledge.

article thumbnail

3 shifts in healthcare to expect from telehealth innovations in 2023

MedCity News

The telehealth industry will continue to drive innovation that helps bring telehealth more permanently and creatively into the care continuum. You’ll see device integration and be able to perform even more complicated tests, like dialysis, at home.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MHRA approves Pluvicto® and Locametz® for prostate cancer

European Pharmaceutical Review

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for Pluvicto ® (lutetium [ 177 Lu] vipivotide tetraxetan), for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy or who are not medically suitable for taxanes.

Medicine 111
article thumbnail

The PM360 Trailblazer Awards 2022 Finalists

PM360

The finalists are in for PM360’s 14 th annual Trailblazer Awards. The Trailblazer Awards were established in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The Trailblazer Awards honor achievements in eight overall categories, including Companies of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champion

Education 105
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Voice transcription AI: The future of doctor-patient interactions

MedCity News

Voice-recognition AI software has the potential to be the rare smartphone app that encourages face-to-face interactions. Its early results suggest the technology could be a game-changer for a healthcare industry in desperate need of one, boosting morale in the short-term while potentially saving money down the road.

Doctors 104
article thumbnail

GSK gets June 2023 FDA decision date for momelotinib

pharmaphorum

The clock is now ticking on the FDA’s review of GSK’s momelotinib for myelofibrosis patients with anaemia – the centrepiece of its $1.9 billion acquisition of Sierra Oncology which completed last month. The US regulator is due to make a decision on momelotinib by 16 June, 2023, on the basis of phase 3 results reported in January, said GSK.

FDA 104

More Trending

article thumbnail

Woman of the Week: Takeda Oncology’s Teresa Bitetti

PharmaVoice

Upon joining Takeda Pharmaceuticals as president of the global oncology unit, Teresa Bitetti had two important goals: to transform the business and create greater synergies between commercial and R&D operations.

article thumbnail

Hearing experts applaud FDA approval of over the counter hearing aids

MedCity News

The FDA’s final rule could make hearing aids available as soon as October. With nearly 30 million American adults struggling with some form of hearing loss, the change will greatly expand access to hearing care, experts say.

FDA 98
article thumbnail

IN FOCUS: Northgate Technologies

Pharmaceutical Technology

RANKINGS 2022 Excellence Innovation Commended Excellence Product Launch Commended Excellence Safety Commended. The Verdict. Northgate Technologies Inc. (NTI) is a Illinois based producer of medical devices and technologies for the healthcare sector, with a particular focus on surgical environments. The company is ranked in the 2022 Excellence Rankings in the INNOVATION , PRODUCT LAUNCH and SAFETY categories.

article thumbnail

How real-time benefit tools deliver meaningful savings

MedCity News

In a rapidly changing and expanding healthcare environment, the secure exchange of health information and price transparency enabled by real-time benefit tools is critical to improve patient safety, lower costs and ensure quality care.

Safety 98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Inventing the COVID vax pill: a matter of convenience and durability

PharmaVoice

Recent data from Vaxart’s phase 1 trial of its COVID-19 inoculation pill shows potential.

130
130
article thumbnail

KeyCare gets $24M to expand the only virtual care platform built on Epic

MedCity News

KeyCare, the country’s only virtual-first care platform built with Epic, recently closed a $24 million Series A funding round. It will use the money to go live at more health systems and onboard more virtual care providers to its platform.

98
article thumbnail

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise

pharmaphorum

Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five new drug targets — and possibly spending more than a billion in milestone payments and tiered royalties when all is said and done. The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop.

article thumbnail

Bluebird Bio gene therapy wins first FDA approval for rare blood disorder

MedCity News

FDA approval of Bluebird Bio’s Zynteglo makes it the first gene therapy in the U.S. for the rare blood disorder beta thalassemia. The biotech company set a $2.8 million price for the one-time treatment, but it also came up with a reimbursement strategy designed to ease the financial risk to payers.

FDA 98
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Tackling the silent pandemic: AMR Industry Alliance sets the Standard

European Pharmaceutical Review

Antimicrobial resistance (AMR) is a growing concern worldwide. Recognised as one of the top 10 global health changes by the World Health Organization (WHO), 1 it was found to have played a role in 4.95 million deaths in 2019 and been the direct cause of 1.27 million of these, 2 meaning drug-resistant infections killed more people than HIV/AIDS (864,000 deaths) or malaria (643,000 deaths). 3 Just six resistant bacteria accounted for almost 80 percent of the direct deaths, with antibiotic-resistan

article thumbnail

Sanofi drops out of competitive breast cancer drug race after another trial failure

MedCity News

Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule. The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.

article thumbnail

Get Well takes digital approach to tackling monkeypox

pharmaphorum

With monkeypox now officially declared a public health emergency in the US, digital health company Get Well has developed a management plan to track people infected with monkeypox and help to deliver their care. The company says the digital monkeypox symptom monitoring tool takes the form of a 21-day care plan that educates patients about monkeypox and how it transmits, explains what symptoms look like, and gives advice on what they should do if they develop symptoms.

article thumbnail

3 ways to reform the pharmacy benefits industry

MedCity News

At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and

article thumbnail

Highmark, Posit Science partner to prevent falls among members

MedCity News

Posit Science has an app called BrainHQ, which provides exercises for memory, brain speed, attention and other areas. Highmark Wholecare is specifically offering the product to members who are at a high risk of falling.

97
article thumbnail

Formulation development outsourcing market to be worth over $60bn by 2030

European Pharmaceutical Review

According to a recent report , the global formulation development outsourcing market size should grow to $61.4 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.2 percent from its 2022 value of $35.1 billion. The investigators found that the high burden of chronic and infectious diseases, growing focus on bioavailability enhancement for poorly soluble drugs, and the challenges associated with drug development were the major contributors to the demand for formulation develop

article thumbnail

How to Make Sure Your Corporate Pharmaceutical ESG Strategy Is Appealing to Younger Generations

PharmExec

Environmental, social, and governance (ESG) standards are becoming more important for modern investors.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

LifeArc and Great Ormond Street Hospital charity award £1.3m to tackle diseases

PharmaTimes

Funds will allow researchers to focus on improving the lives of children with rare conditions

89
article thumbnail

UK life science competitiveness indicators 2022: measuring what matters most?

pharmaphorum

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. The indicators did not bring universal good news , but Leela Barham argues we need to consider whether the indicators are measuring what matters most if we are to understand more about the health of the UK life sciences industry and, most importantly, what it means for patients.

article thumbnail

Merck and Orna partner for RNA technology-based vaccines and therapies

Pharmaceutical Technology

Merck (MSD outside North America) has entered a partnership agreement with Orna Therapeutics for discovering, developing and marketing various programmes based on next-generation RNA technology. These programmes will include therapies and vaccines in infectious disease and oncology areas. By self-circularisation, Orna’s oRNA technology makes circular ribonucleic acids (oRNAs) from linear RNAs. oRNA molecules have been demonstrated to possess increased stability in vivo compared to linear mRNA an

article thumbnail

Respiratory Monitoring & AI Technologies

pharmaphorum

Returning for the 2nd annual year, the Biosensors for Medical Wearables Conference will be held in October 24 – 25 2022 in Boston, MA, USA. Delegates will have the chance to network and connect with the likes of: Pfizer, MedRhythms, Digital Medicine Society, AstraZeneca, CardioSignal, Neursantys, ActiGraph, PyrAmes, HexoSkin, TracPatch Health and many others.

Media 59
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

How to Lead and Succeed in the Biosimilars Space

PharmExec

Key traits needed by leaders looking to grow their organizations in the biosimilars market.

Leads 83
article thumbnail

Sanofi provides update on amcenestrant

PharmaTimes

The company’s clinical development programme is to be discontinued following a recent evaluation

80
article thumbnail

Livestreaming and Retention

Verb

By now, you are probably well aware of the benefits of livestream selling and its monumental impact in China. For instance, you may have heard that Kim Kardashian sold 150,000 bottles of perfume (her entire stock of the product) in mere minutes when she appeared as a guest on a popular Chinese livestream show. But what you might not know is that there is one key benefit to livestream selling that is often overlooked—retention.

article thumbnail

Health Equity: Clinical Development’s Future Framework

PharmExec

Thu, Aug 18, 2022 2:00 PM EDT Value for patients, value for all. Learn how today’s health equity initiatives are shaping best-in-class clinical development frameworks of the future.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.